Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 01, 2023

SELL
$8.96 - $10.75 $385 - $462
-43 Reduced 36.44%
75 $0
Q2 2023

Aug 04, 2023

BUY
$9.39 - $12.18 $1,108 - $1,437
118 New
118 $1,000
Q2 2022

Aug 03, 2022

SELL
$5.35 - $10.11 $1,514 - $2,861
-283 Closed
0 $0
Q1 2022

May 02, 2022

BUY
$7.93 - $13.33 $2,244 - $3,772
283 New
283 $2,000

Others Institutions Holding CELC

About Celcuity Inc.


  • Ticker CELC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 14,941,300
  • Market Cap $190M
  • Description
  • Celcuity Inc., a clinical stage biotechnology company, focuses on the development of molecularly targeted therapies for cancer patients in the United States. The company's CELsignia diagnostic platform uses a patient's living tumor cells to identify the specific abnormal cellular process driving a patient's cancer and the related targeted therap...
More about CELC
Track This Portfolio

Track Simplex Trading, LLC Portfolio

Follow Simplex Trading, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Simplex Trading, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Simplex Trading, LLC with notifications on news.